Skip to main content
Trending storyContinuously updated

Isomorphic Labs in talks to raise $5B at $50B valuation

1 reports1 report sources1 hours agoUpdate

Get up to speed on this story

AI Summary

Isomorphic Labs, the drug-discovery company spun out of Google DeepMind and founded by Demis Hassabis, is in talks to raise $5 billion at a $50 billion valuation, Bloomberg reported, citing people familiar with the matter. The financing is not final and terms may change. Hassabis expects the company's first clinical trials to begin by the end of December. If the $5 billion round closes, Isomorphic Labs will have raised roughly $7.7 billion in external funding in under two years.

AI-generated from reports · 18 minutes agoUpdate

Latest updatesNov 5 18:56
Isomorphic Labs in Talks to Raise $5B at $50B Valuation

Report timeline

Follow the reports to understand different sides of the story.

Nov 5
  1. Tech Funding News
    Isomorphic Labs in Talks to Raise $5B at $50B Valuation

    Isomorphic Labs is in talks to raise $5 billion at a $50 billion valuation, per Bloomberg.

Trend for this story

Not enough continuous observation data yet; trend chart is not drawn for now.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing